| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.002 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.49 | 0.004 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |